Prostate Cancer

Cancer is often treated as a condition that absolutely must receive treatment, yet prostate cancer does not always need to be treated, and there are some pros to not treating it. Screening for cancer through a prostate-specific antigen (PSA) has also faced some scrutiny. Fewer than one in three men who screen for the antigen ...click here to read more

Researchers may have found yet another reason that getting the necessary shut-eye is so important, especially for men. According to a new preliminary study, sleep deprivation may be linked to fatal prostate cancer. A study analyzed long-term data from more than 823,000 men in the United States and found that men younger than 65 years ...click here to read more

It is said that every man, if able to live long enough, will most likely develop prostate cancer—a relatively slow growing cancer that about 99 percent of the time occurs over the age of 50. The prostate is a gland and part of the male reproductive system that aids in the secretion of alkaline fluid, ...click here to read more

Prostate cancer is one of the most common male cancers, though many men are unaware of the factors that put them at risk. While it is important to get checked regularly, you may want to increase the frequency of your screening appointments depending on whether you have any of these risk factors. Obesity. Are you ...click here to read more

If you’re an older male then your doctor may have discussed with you a prostate-specific antigen (PSA) test. PSA is a protein produced by the prostate and found in the blood. The value of the PSA blood test is that it can offer some important insight into your health, including the possibility of prostate cancer. ...click here to read more

An analysis of 27 studies has found that alcohol consumption can increase the risk of prostate cancer among men. The researchers found that even limited drinking – two drinks a day – was associated with an eight to 23 percent higher risk of prostate cancer, compared to no drinking at all. Coauthor Tim Stockwell explained, ...click here to read more

Prostate cancer patients taking testosterone-lowering drugs may be twice as likely to develop dementia. The researchers found that males who underwent androgen-deprivation therapy (ADT) had an eight percent risk of dementia within five years of treatment, compared to only 3.5 percent among those who did not receive ADT. Lead researcher Dr. Kevin Nead said, “People ...click here to read more

Eating walnuts may reduce the risk of heart disease, diabetes, and prostate cancer, as well as improve colon health, according to different studies. The Connecticut-based research center conducted a study among 46 adults aged 30 to 75. All of the participants were overweight with BMIs greater than 25. Men had waist circumferences larger than 40 ...click here to read more

Elevated cholesterol and triglycerides increase prostate cancer recurrence risk, according to research. Researcher Emma Allott said, “While laboratory studies support an important role for cholesterol in prostate cancer, population-based evidence linking cholesterol and prostate cancer is mixed. Understanding associations between obesity, cholesterol, and prostate cancer is important, given that cholesterol levels are readily modifiable with ...click here to read more

Parkinson’s disease (PD) may increase prostate cancer or melanoma risk according to research. The results of the study support a genetic link between prostate cancer, melanoma, and Parkinson’s disease. Coauthor Lisa Cannon-Albright explained, “The clinical implications suggest screening for melanoma and prostate cancer in appropriate PD patients and, perhaps, vice versa.” The researchers looked at ...click here to read more

Prostate cancer patients on androgen deprivation therapy (ADT) face the risk of Alzheimer’s disease, but type 2 diabetics are less likely to develop prostate cancer, according to research. The first study does not prove a cause-and-effect relationship, but merely shows an association between ADT and Alzheimer’s disease. Lead author Dr. Kevin T. Nead said, “We ...click here to read more

A recent study published in BJU International states that certain prostate cancer medications can increase the risk of heart-related deaths in men with congestive heart failure or prior heart attacks. Researchers led by David Ziehr of Harvard Medical School and Paul Nguyen, MD, of the Dana-Farber/Brigham and Women’s Cancer Center, found that a common prostate ...click here to read more

Prostate cancer patients on active surveillance may have metastasis. Metastasis is a term used to describe the spread of cancer to another part of the body. Prostate cancer, specifically, can spread to the bones as well as the liver or the lungs. Spreading to the brain, on the other hand, is rare for prostate cancer. ...click here to read more

Prostate cancer risk in men increases with high blood pressure, blood sugar, and body mass index. Researchers looked at 289,866 men enrolled in a study called the Metabolic Syndrome and Cancer Project. With the average follow-up time of 12 years, 6,673 men were diagnosed with prostate cancer and 961 died from the disease. Men with ...click here to read more